Which has preferable earnings & valuation, RDNT or GH?

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.82 -$18.65M -$0.27 N/A Guardant Health $982.02M 24.09 -$416.28M -$3.49 N/A

Does the media refer more to RDNT or GH?

In the previous week, Guardant Health had 12 more articles in the media than RadNet. MarketBeat recorded 16 mentions for Guardant Health and 4 mentions for RadNet. RadNet's average media sentiment score of 0.33 beat Guardant Health's score of 0.21 indicating that RadNet is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Guardant Health 6 Very Positive mention(s) 1 Positive mention(s) 3 Neutral mention(s) 1 Negative mention(s) 1 Very Negative mention(s) Neutral

Does the media favor FMS or RDNT?

In the previous week, RadNet had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for RadNet and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat RadNet's score of 0.33 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Fresenius Medical Care AG & Co. KGaA 1 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive RadNet 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media refer more to RDNT or BTSG?

In the previous week, RadNet had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 4 mentions for RadNet and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat RadNet's score of 0.33 indicating that BrightSpring Health Services is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral BrightSpring Health Services 2 Very Positive mention(s) 0 Positive mention(s) 0 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has higher valuation and earnings, RDNT or DVA?

DaVita has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.82 -$18.65M -$0.27 N/A DaVita $13.64B 0.86 $746.80M $12.22 14.98

Is RDNT or DVA more profitable?

DaVita has a net margin of 6.05% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.61% beat DaVita's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.93% 2.61% 0.91% DaVita 6.05% -217.63% 5.07%

Does the media refer more to RDNT or DVA?

In the previous week, DaVita had 8 more articles in the media than RadNet. MarketBeat recorded 12 mentions for DaVita and 4 mentions for RadNet. DaVita's average media sentiment score of 0.88 beat RadNet's score of 0.33 indicating that DaVita is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral DaVita 7 Very Positive mention(s) 1 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, RDNT or TEM?

RadNet has higher revenue and earnings than Tempus AI. RadNet is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio RadNet $2.04B 2.82 -$18.65M -$0.27 N/A Tempus AI $1.27B 10.87 -$245.03M -$1.44 N/A

Is RDNT or TEM more profitable?

RadNet has a net margin of -0.93% compared to Tempus AI's net margin of -17.77%. RadNet's return on equity of 2.61% beat Tempus AI's return on equity. Company Net Margins Return on Equity Return on Assets RadNet -0.93% 2.61% 0.91% Tempus AI -17.77% -50.28% -10.33%

Does the media refer more to RDNT or TEM?

In the previous week, Tempus AI had 36 more articles in the media than RadNet. MarketBeat recorded 40 mentions for Tempus AI and 4 mentions for RadNet. Tempus AI's average media sentiment score of 0.57 beat RadNet's score of 0.33 indicating that Tempus AI is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment RadNet 0 Very Positive mention(s) 2 Positive mention(s) 2 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral Tempus AI 17 Very Positive mention(s) 4 Positive mention(s) 11 Neutral mention(s) 2 Negative mention(s) 0 Very Negative mention(s) Positive

RadNet (RDNT) Competitors

$73.21 -0.72 (-0.97%)

Closing price 04:00 PM Eastern

Extended Trading

$73.18 -0.03 (-0.05%)

As of 07:30 PM Eastern

Compare

RDNT vs. GH, FMS, BTSG, DVA, and TEM

Should you buy RadNet stock or one of its competitors? RadNet's main competitors and comparable companies include Guardant Health (GH), Fresenius Medical Care AG & Co. KGaA (FMS), BrightSpring Health Services (BTSG), DaVita (DVA), and Tempus AI (TEM). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "healthcare services" industry.

How does RadNet compare to Guardant Health?

RadNet (NASDAQ:RDNT) and Guardant Health (NASDAQ:GH) are both healthcare companies, but which is the better investment? We will compare the two companies based on the strength of their valuation, institutional ownership, profitability, earnings, media sentiment, dividends, risk and analyst recommendations.

RadNet has higher revenue and earnings than Guardant Health. RadNet is trading at a lower price-to-earnings ratio than Guardant Health, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.82	-$18.65M	-$0.27	N/A
Guardant Health	$982.02M	24.09	-$416.28M	-$3.49	N/A

RadNet has a net margin of -0.93% compared to Guardant Health's net margin of -38.33%. RadNet's return on equity of 2.61% beat Guardant Health's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Guardant Health	-38.33%	N/A	-25.40%

77.9% of RadNet shares are held by institutional investors. Comparatively, 92.6% of Guardant Health shares are held by institutional investors. 5.1% of RadNet shares are held by company insiders. Comparatively, 5.6% of Guardant Health shares are held by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.

In the previous week, Guardant Health had 12 more articles in the media than RadNet. MarketBeat recorded 16 mentions for Guardant Health and 4 mentions for RadNet. RadNet's average media sentiment score of 0.33 beat Guardant Health's score of 0.21 indicating that RadNet is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Guardant Health	6 Very Positive mention(s)	1 Positive mention(s)	3 Neutral mention(s)	1 Negative mention(s)	1 Very Negative mention(s)	Neutral

RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Guardant Health has a beta of 1.57, indicating that its share price is 57% more volatile than the broader market.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 22.93%. Guardant Health has a consensus price target of $188.13, suggesting a potential upside of 6.70%. Given RadNet's higher possible upside, analysts plainly believe RadNet is more favorable than Guardant Health.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Guardant Health	1 Sell rating(s)	0 Hold rating(s)	24 Buy rating(s)	1 Strong Buy rating(s)	2.96

Summary

RadNet beats Guardant Health on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Fresenius Medical Care AG & Co. KGaA (NYSE:FMS) and RadNet (NASDAQ:RDNT) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their institutional ownership, media sentiment, valuation, earnings, analyst recommendations, profitability, risk and dividends.

Fresenius Medical Care AG & Co. KGaA presently has a consensus price target of $23.57, suggesting a potential upside of 5.04%. RadNet has a consensus price target of $90.00, suggesting a potential upside of 22.93%. Given RadNet's stronger consensus rating and higher possible upside, analysts clearly believe RadNet is more favorable than Fresenius Medical Care AG & Co. KGaA.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Fresenius Medical Care AG & Co. KGaA	5 Sell rating(s)	6 Hold rating(s)	0 Buy rating(s)	0 Strong Buy rating(s)	1.55
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89

8.4% of Fresenius Medical Care AG & Co. KGaA shares are held by institutional investors. Comparatively, 77.9% of RadNet shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a stock is poised for long-term growth.

Fresenius Medical Care AG & Co. KGaA has a beta of 0.76, meaning that its stock price is 24% less volatile than the broader market. Comparatively, RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market.

Fresenius Medical Care AG & Co. KGaA has a net margin of 4.83% compared to RadNet's net margin of -0.93%. Fresenius Medical Care AG & Co. KGaA's return on equity of 9.28% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Fresenius Medical Care AG & Co. KGaA	4.83%	9.28%	4.16%
RadNet	-0.93%	2.61%	0.91%

Fresenius Medical Care AG & Co. KGaA has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than Fresenius Medical Care AG & Co. KGaA, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Fresenius Medical Care AG & Co. KGaA	$22.20B	0.54	$1.11B	$1.93	11.62
RadNet	$2.04B	2.82	-$18.65M	-$0.27	N/A

In the previous week, RadNet had 3 more articles in the media than Fresenius Medical Care AG & Co. KGaA. MarketBeat recorded 4 mentions for RadNet and 1 mentions for Fresenius Medical Care AG & Co. KGaA. Fresenius Medical Care AG & Co. KGaA's average media sentiment score of 1.44 beat RadNet's score of 0.33 indicating that Fresenius Medical Care AG & Co. KGaA is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Fresenius Medical Care AG & Co. KGaA	1 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

Summary

RadNet beats Fresenius Medical Care AG & Co. KGaA on 9 of the 17 factors compared between the two stocks.

How does RadNet compare to BrightSpring Health Services?

RadNet (NASDAQ:RDNT) and BrightSpring Health Services (NASDAQ:BTSG) are both healthcare companies, but which is the superior business? We will contrast the two companies based on the strength of their valuation, earnings, profitability, media sentiment, dividends, analyst recommendations, risk and institutional ownership.

In the previous week, RadNet had 2 more articles in the media than BrightSpring Health Services. MarketBeat recorded 4 mentions for RadNet and 2 mentions for BrightSpring Health Services. BrightSpring Health Services' average media sentiment score of 1.10 beat RadNet's score of 0.33 indicating that BrightSpring Health Services is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
BrightSpring Health Services	2 Very Positive mention(s)	0 Positive mention(s)	0 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has a beta of 1.41, suggesting that its stock price is 41% more volatile than the broader market. Comparatively, BrightSpring Health Services has a beta of 1.84, suggesting that its stock price is 84% more volatile than the broader market.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 22.93%. BrightSpring Health Services has a consensus price target of $70.71, suggesting a potential upside of 26.76%. Given BrightSpring Health Services' stronger consensus rating and higher possible upside, analysts plainly believe BrightSpring Health Services is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
BrightSpring Health Services	0 Sell rating(s)	0 Hold rating(s)	18 Buy rating(s)	2 Strong Buy rating(s)	3.10

77.9% of RadNet shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 2.8% of BrightSpring Health Services shares are owned by company insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a stock will outperform the market over the long term.

BrightSpring Health Services has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than BrightSpring Health Services, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.82	-$18.65M	-$0.27	N/A
BrightSpring Health Services	$12.91B	0.85	$190.67M	$1.66	33.60

BrightSpring Health Services has a net margin of 2.55% compared to RadNet's net margin of -0.93%. BrightSpring Health Services' return on equity of 16.73% beat RadNet's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
BrightSpring Health Services	2.55%	16.73%	5.24%

Summary

BrightSpring Health Services beats RadNet on 12 of the 16 factors compared between the two stocks.

How does RadNet compare to DaVita?

RadNet (NASDAQ:RDNT) and DaVita (NYSE:DVA) are both healthcare companies, but which is the better investment? We will compare the two businesses based on the strength of their institutional ownership, media sentiment, dividends, valuation, risk, profitability, earnings and analyst recommendations.

RadNet presently has a consensus price target of $90.00, suggesting a potential upside of 22.93%. DaVita has a consensus price target of $233.43, suggesting a potential upside of 27.50%. Given DaVita's higher probable upside, analysts plainly believe DaVita is more favorable than RadNet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
DaVita	0 Sell rating(s)	3 Hold rating(s)	4 Buy rating(s)	0 Strong Buy rating(s)	2.57

RadNet has a beta of 1.41, meaning that its stock price is 41% more volatile than the broader market. Comparatively, DaVita has a beta of 0.83, meaning that its stock price is 17% less volatile than the broader market.

DaVita has higher revenue and earnings than RadNet. RadNet is trading at a lower price-to-earnings ratio than DaVita, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.82	-$18.65M	-$0.27	N/A
DaVita	$13.64B	0.86	$746.80M	$12.22	14.98

DaVita has a net margin of 6.05% compared to RadNet's net margin of -0.93%. RadNet's return on equity of 2.61% beat DaVita's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
DaVita	6.05%	-217.63%	5.07%

77.9% of RadNet shares are owned by institutional investors. Comparatively, 90.1% of DaVita shares are owned by institutional investors. 5.1% of RadNet shares are owned by company insiders. Comparatively, 1.9% of DaVita shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

In the previous week, DaVita had 8 more articles in the media than RadNet. MarketBeat recorded 12 mentions for DaVita and 4 mentions for RadNet. DaVita's average media sentiment score of 0.88 beat RadNet's score of 0.33 indicating that DaVita is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
DaVita	7 Very Positive mention(s)	1 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Summary

DaVita beats RadNet on 10 of the 17 factors compared between the two stocks.

How does RadNet compare to Tempus AI?

RadNet (NASDAQ:RDNT) and Tempus AI (NASDAQ:TEM) are both healthcare companies, but which is the better stock? We will compare the two companies based on the strength of their risk, analyst recommendations, dividends, institutional ownership, earnings, media sentiment, valuation and profitability.

RadNet presently has a consensus target price of $90.00, indicating a potential upside of 22.93%. Tempus AI has a consensus target price of $69.63, indicating a potential downside of 9.09%. Given RadNet's stronger consensus rating and higher probable upside, analysts clearly believe RadNet is more favorable than Tempus AI.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
RadNet	1 Sell rating(s)	1 Hold rating(s)	5 Buy rating(s)	2 Strong Buy rating(s)	2.89
Tempus AI	2 Sell rating(s)	9 Hold rating(s)	11 Buy rating(s)	0 Strong Buy rating(s)	2.41

RadNet has a beta of 1.41, indicating that its share price is 41% more volatile than the broader market. Comparatively, Tempus AI has a beta of 3.72, indicating that its share price is 272% more volatile than the broader market.

RadNet has a net margin of -0.93% compared to Tempus AI's net margin of -17.77%. RadNet's return on equity of 2.61% beat Tempus AI's return on equity.

Company	Net Margins	Return on Equity	Return on Assets
RadNet	-0.93%	2.61%	0.91%
Tempus AI	-17.77%	-50.28%	-10.33%

In the previous week, Tempus AI had 36 more articles in the media than RadNet. MarketBeat recorded 40 mentions for Tempus AI and 4 mentions for RadNet. Tempus AI's average media sentiment score of 0.57 beat RadNet's score of 0.33 indicating that Tempus AI is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
RadNet	0 Very Positive mention(s)	2 Positive mention(s)	2 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral
Tempus AI	17 Very Positive mention(s)	4 Positive mention(s)	11 Neutral mention(s)	2 Negative mention(s)	0 Very Negative mention(s)	Positive

RadNet has higher revenue and earnings than Tempus AI. RadNet is trading at a lower price-to-earnings ratio than Tempus AI, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
RadNet	$2.04B	2.82	-$18.65M	-$0.27	N/A
Tempus AI	$1.27B	10.87	-$245.03M	-$1.44	N/A

77.9% of RadNet shares are held by institutional investors. Comparatively, 24.2% of Tempus AI shares are held by institutional investors. 5.1% of RadNet shares are held by insiders. Comparatively, 24.3% of Tempus AI shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

RadNet beats Tempus AI on 10 of the 17 factors compared between the two stocks.

Get RadNet News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding RDNT and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

RDNT vs. The Competition

Export

Metric	RadNet	Healthcare Providers & Services Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$5.82B	$9.76B	$7.32B	$13.29B
Dividend Yield	N/A	2.59%	2.52%	12.57%
P/E Ratio	-271.14	29.04	209.51	20.92
Price / Sales	2.82	4.96	649.76	88.01
Price / Cash	22.93	122.11	77.80	52.76
Price / Book	4.16	5.20	10.44	6.32
Net Income	-$18.65M	$315.70M	$3.49B	$359.73M
7 Day Performance	-3.39%	-1.36%	0.51%	1.35%
1 Month Performance	-4.70%	-2.74%	-3.38%	-3.68%
1 Year Performance	-5.22%	11.52%	16.04%	5.56%

RadNet Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
RDNT RadNet	2.8682 of 5 stars	$73.21 -1.0%	$90.00 +22.9%	-2.3%	$5.82B	$2.04B	N/A	11,264	Analyst Forecast
GH Guardant Health	2.1811 of 5 stars	$167.84 +6.6%	$188.13 +12.1%	+196.4%	$21.12B	$1.18B	N/A	2,506
FMS Fresenius Medical Care AG & Co. KGaA	2.8588 of 5 stars	$22.86 +2.3%	$23.57 +3.1%	-12.2%	$12.00B	$22.20B	11.84	1,488
BTSG BrightSpring Health Services	4.6864 of 5 stars	$60.30 +2.7%	$70.71 +17.3%	+104.9%	$11.62B	$12.91B	36.33	23,500	Positive News
DVA DaVita	4.6486 of 5 stars	$189.66 +4.5%	$233.43 +23.1%	+39.7%	$11.58B	$14.01B	15.52	78,000

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:RDNT) was last updated on 9/23/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, DVA, and TEM

How does RadNet compare to Guardant Health?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Summary

How does RadNet compare to BrightSpring Health Services?

Summary

How does RadNet compare to DaVita?

Summary

How does RadNet compare to Tempus AI?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

RadNet (RDNT) Competitors

RDNT vs. GH, FMS, BTSG, DVA, and TEM

How does RadNet compare to Guardant Health?

Which has preferable earnings & valuation, RDNT or GH?

Is RDNT or GH more profitable?

Do insiders & institutionals have more ownership in RDNT or GH?

Does the media refer more to RDNT or GH?

Which has more volatility and risk, RDNT or GH?

Do analysts recommend RDNT or GH?

Summary

How does RadNet compare to Fresenius Medical Care AG & Co. KGaA?

Do analysts prefer FMS or RDNT?

Do insiders and institutionals have more ownership in FMS or RDNT?

Which has more risk & volatility, FMS or RDNT?

Is FMS or RDNT more profitable?

Which has better earnings and valuation, FMS or RDNT?

Does the media favor FMS or RDNT?

Summary

How does RadNet compare to BrightSpring Health Services?

Does the media refer more to RDNT or BTSG?

Which has more risk & volatility, RDNT or BTSG?

Do analysts recommend RDNT or BTSG?

Do institutionals and insiders hold more shares of RDNT or BTSG?

Which has better valuation and earnings, RDNT or BTSG?

Is RDNT or BTSG more profitable?

Summary

How does RadNet compare to DaVita?

Do analysts rate RDNT or DVA?

Which has more volatility & risk, RDNT or DVA?

Which has higher valuation and earnings, RDNT or DVA?

Is RDNT or DVA more profitable?

Do insiders & institutionals hold more shares of RDNT or DVA?

Does the media refer more to RDNT or DVA?

Summary

How does RadNet compare to Tempus AI?

Do analysts rate RDNT or TEM?

Which has more volatility & risk, RDNT or TEM?

Is RDNT or TEM more profitable?

Does the media refer more to RDNT or TEM?

Which has better valuation and earnings, RDNT or TEM?

Do insiders & institutionals believe in RDNT or TEM?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

RDNT vs. The Competition

RadNet Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools